Latest updates
- Awards Exonate finalists for OBN’s 2020 Most Impactful UK Deal Award
- Company news Exonate receives regulatory approval to start Phase I Clinical Trials in Australia
- Company news Exonate completes Wellcome Trust Seeding Drug Discovery Award programme
- In the press A day in the life of a Senior Scientist
- In the press Exonate Announces Collaboration with Janssen to develop a new eye drop for the treatment of retinal vascular diseases including wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO)
- Insights Exonate at RANZCO – 8-12th November 2019, International Convention Centre Sydney (ICC)